Volume of procedures and outcome of treatment
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7368.787 (Published 12 October 2002) Cite this as: BMJ 2002;325:787All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
I have agreed with Bosset et al that the operative mortality of 10%
for oesophagectomy reported by the Medical Research Council (MRC)
Oesophageal Cancer Working Party is unacceptably high. I have also
observed that the operative mortality of 12.7% reported in the General
Infirmary in Leeds is equally unacceptable (1). The operative mortality
in Bosset et al’s hands (3.2%) and Orringer’s (4%) and Skinner’s (3.9%)
latest reports of their data was very much lower (2). These two surgeons
are amongst the best known oesophageal surgeons in the country. Upon
further review of the literature I find I overlooked that Skinner had an
operative mortality of 11% when he reported the results of his first 100
cases of en bloc oesophagectomy , an equally unacceptable figure (3). It
is of concern that even if none of the additional 28 patients he reported
in his series had not died his operative mortality should have been only
as low as 8.5% and not as low as 3.9%. How then did he come up with the
sanitised figure of 3.9% especially as Altorki is a co-author on both
publications? Might these be the cases from New York Hospital performed by
the third co-author, Giradi, in his latest report? If so he must have
discarded all or some of the patients he operated upon when he was
chairman of surgery at the University of Chicago.
Skinner, a product of the Halstead surgical tradition at The Johns
Hopkins, has published 220 papers in scientific journals, many of them on
oesophageal diseases. In the case of oesophagectomy for cancer his
contention is that mediastinal lymph node removal improves outcome, a
debatable point especially as his operative mortality is so unacceptably
high (4). He is nevertheless one of the most prominent surgeons in the US
surgery and has been especially active in the surgical and cardiothoracic
surgical societies (4,5). As president of New York Hospital he has been
instrumental in their establishing a Paris affiliation, apparently with
the intention of extending US healthcare into Europe. It is not surprising
that he has been actively involved in healthcare reform in the US,
seemingly playing an important part in establishing the political
correctness of surgical practice (6) . He and his peers who have both
general surgery and subspecalty boards are firm believers in the need for
board certification to be granted privileges in a private hospital and for
subspecialty boards to be granted privileges in subspecialty surgery,
certainly in the US. Recertification of these privileges is another issue
with which he is particularly familiar (7). That position, if carried to
its logical conclusion and includes in addition to cardiothoracic surgery
colo-rectal surgery, paediatric surgery, orthopaedic surgery and other
established or candidate subspecialties, such as vascular surgery.
Vascular surgery, previously firmly within general surgery, is sitting on
the fence on this issue but seems likely to jump into bed with the sub-
specialists.
I have had some experience with the political implications these
political dealings. As chief of the surgical services at the Brooklyn VA
for a brief period I inherited a string of misadventures. The most
striking concerned an army veteran in his early sixties who had had weeks
before I arrived a curative resection for premalignant changes in a
Barrett’s oesophagus. The operation had been performed by a chief
resident in the last year of his general surgical training assisted by a
thoracic surgeon in private practice who was one a several covering the
service on a rotation. The operation had been a disaster. The oesophagus
has been replaced with a colonic interposition that had been made far too
long. The top end had been anastomosed in end-to-side fashion with the
formation of what was in effect a large pharyngeal pouch. When the
patient was not able to swallow they investigated him supposedly with
upper endoscopy performed by the gastroenterologists. I was informed by
the chief resident that they had found a “cesspool” in the stomach
indicative of gastric stasis. A barium swallow performed later revealed a
long ischaemic stricture extending throughout the upper two thirds of the
interposed colon.
I asked the chief resident why they had not used the stomach instead
of the colon. “Because his stomach was irradiated for a lymphoma” he
replied, a statement which I was never able to confirm. He added that the
pyloroplasty had been performed in two layers, an operation abandoned
decades ago because of the stasis is caused. I then asked the surgical
resident who had assisted him and why he had made a two layered
pyloroplasty. “Oh,” said the thoracic surgeon “ I always use a stapler” ,
not in my book a good way of making a pyloroplasty but a single layered
one. It transpired that the chairman of surgery at the affiliated
university from which the residents came had decreed that chief residents
were to be given responsible for the care of all general surgical
operations including oesophageal resections. The thoracic surgeons, who
believed the oesophagus was their territory, responded by working to rule
and doing exactly as the resident asked even when they knew it to be wrong
and appeared even to have attempted to mislead them into making obvious
mistakes. Their intention appears to have been to demonstrate to the
chairman of the surgical training program that chief residents were not
qualified to perform oesophageal surgery even in their final months of
their training and needed to complete a thoracic fellowship before being
qualified to do so.
In attempting to resolve the problem for this poor man, nurses
supportive of the thoracic surgeons, compounded his problems by also
working to rule and neglecting basic nursing care including getting him
out of bed and responding to his repeated requests for assistance unless
there was a doctors’ order written for it. On one occasion that I had
written a very specific order on fluid management then nurses appeared to
have made deliberate errors in his fluid input-output chart to make the
order impossible to follow. The harder I rode heard to insure that proper
care was provided the more disruptive the nursing staff became ultimately
leaving for the medical wards. In the two oesophageal operations I
performed transhiatally with the residents, contrary to Skinner’s views,
and followed very closely myself there were even more blantant efforts
seemingly by nurses to interfere with management.
I ordered an angiogram to look at the blood supply of his stomach.
This showed that the gastroepiploic vessels had been divided thus
eliminating the stomach as a possible replacement for the ischaemic
oesophagus. As he needed a free graft of small intestine to re-establish
gastrointestinal continuity I approached the Sloane Kettering trained
“cancer surgeon” who had evidently been trained in microvascular
techniques for head and neck surgery. He said the VA did not have the
necessary instruments and expressed the opinion that the patient should be
referred elsewhere.
I decided to take the radiographs to Skinner, who worked in a
compewting hospital but was the most appropriate person in the community,
and see if he would assume responsibility for the resolution of his
problems. By this time it had become clear that management of patients in
the VA which was already very bad, not just in the Brooklyn VA but in all
Vas studied in a national audit, had become so dangerously compromised
that I contemplated closing the operating rooms. Having presented the
case to Skinner and a plastic surgeon of his he did not offer to assume
responsibility. Instead he declared that his plastic surgeon would be
happy to come to the VA to construct a free graft after we had formed a
tunnel under the presternal skin with a skin expander. We agreed that
revision of the pylorus was necessary. In short Skinner had made it clear
that he believed that oesophageal cancer should be taken care of thoracic
surgeons, those who were double boarded, and that if general surgeons
wanted to operate on the oesophagus they had to take care of their own
problems. That did not phase me, but my readiness to assume responsibility
appears to have phased them.
I decided to revise the pyloroplasty first converting it into a
Finney, which I did without complication, before tackling the oesophagus.
I did not form a tunnel under the skin as suggested for upon reflection I
thought it was not only unnecessary but an undesirable permanent solution
in a patient who had been cured of his malignant disease and should have
many years left to live. I thought it best to remove the ischaemic colon
for it was likely to create problems in the future, probably through the
left chest and neck, and place the small bowel free graft in the chest. It
was my intention to monitor the viability of the free graft with
tonometers as I had successfully done with another free graft I had asked
the plastic surgeons to construct for me on another patient. This would
have given me the ability to reoperate the moment the blood supply to the
graft became compromised were that to happen in the postoperative course.
I never got the chance for having advised the chief of staff to close the
operating rooms I was asked to resign. When I refused because they had not
addressed my concerns I had expressed to the hospital director about the
deliberate interference of patient care I was relieved of my duties,
brought before a tribunal and fired for “upsetting too many people”. In
short it appears to have been decided that it was not politically correct
for general surgeons to be doing oesophageal surgery. At least the
hospital director was good enough to write me a letter after my dismissal
thanking me for what I had done for her patients.
Skinner remains actively involved in surgical care, evidently for
political reasons (3). His case is that nodal resection, which requires a
formal thoracotomy, improves life survival relative to transhiatal or
blunt oesophagectomy which he believes does not. Orringer, who appears to
have changed the name of the noperation he does from blunt to transhatal
oesophagectomy, appears also to have changed the name for political
reasons. Indeed he makes the copint that he does not do it bluntly anymore
but does the dissection under direct vision. I, on the other hand,
definitely do it bluntly having on one occasion pulled the oesophagus out
with a varicose veins stripper trying a technique that had been reported
in the literature. I presented the case at grand rounds which is attended
by the thoracic surgeons. Perhaps the point has been made is that doing it
bluntly is not an adequate cancer operation, a point Skinner has held for
many years (8). My response to that having had no operative deaths and few
complications is “first do no harm”.
In reviewing the evolution of Orringer’s “transhiatal oesophagectomy
it is evident that his early experience was traumatic to say the least (9-
16). Certainly he encounted a multitude of complications that I never
enountered in my modest series which is more comparable to his earlier
reports in numbers. The complciations that he has repeatedly seen which I
have never seen include entry into the pleural cavity, recurrent nerve
damage, uncontrollable mediastinal heaemorrhage, and mediastinal and
subphrenic abscesses. It is also evident from his review that he gives the
appearance in his latest reports that these complications were uncommon
and unconsequential which they most certainly were not. Indeed his latest
reports are reminiscent of Skinner’s apparent sanitisation of his
operative mortality.
If Orringer and Skinner are the best cardiothoracic surgeons have to
offer I dread to think what kind of results cardiac surgeons who do the
occasional oesophagectomy might be getting especially as the majority of
the operation is done in the abdomen and neck not the chest, regions in
which they have little operative experience. The only conclusion worth
drawing is that subspecialisation has not been in the best interests of
patient care. There are many ways of skinning a cat and mandating one way
or another for political reasons is counterproductive and even
destructive.
1. Fiddian-Green RG. Training is more important than volume
bmj.com/cgi/eletters/325/7368/787#26226, 12 Oct 2002
2. Altorki NK, Skinner DB. En bloc esophagectomy: the first 100
patients.
Hepatogastroenterology. 1990 Aug;37(4):360-3
3. Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves
survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997
Dec;114(6):948-55
4. Skinner DB. Presidential address: Society of University Surgeons.
Recruitment and retention of academic surgeons.
Surgery. 1979 Jul;86(1):1-12.
5. Skinner DB. Shaping the revolution: thoracic surgeons and something
more. Presidential address.
J Thorac Cardiovasc Surg. 1997 Nov;114(5):699-706.
6. Skinner DB.Implications of United States healthcare reform for
European cardiothoracic surgery.
Eur J Cardiothorac Surg. 1997 Apr;11(4):599-603.
7. Skinner DB. Recertification: is it worthwhile?
Bull Am Coll Surg. 1981 Nov;66(11):9-11.
8. Skinner DB. Invited letter concerning: how extensive should lymph
node dissection be for cancer of the thoracic esophagus? J Thorac
Cardiovasc Surg. 1994 Apr;107(4):1154-5.
9. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy
for treatment of benign and malignant esophageal disease. World J Surg.
2001 Feb;25(2):196-203. Review
10. Orringer MB, Marshall B, Stirling MC. Transhiatal esophagectomy for
benign and malignant disease.
J Thorac Cardiovasc Surg. 1993 Feb;105(2):265-76; discussion 276-7.
11. Orringer MB. Transhiatal esophagectomy without thoracotomy for
carcinoma of the thoracic esophagus. Ann Surg. 1984 Sep;200(3):282-8.
12. Orringer MB. Substernal gastric bypass of the excluded esophagus--
results of an ill-advised operation. Surgery. 1984 Sep;96(3):467-70.
13. Orringer MB. Technical aids in performing transhiatal esophagectomy
without thoracotomy.
Ann Thorac Surg. 1984 Aug;38(2):128-32.
14. Orringer MB, Sloan H. Substernal gastric bypass of the excluded
thoracic esophagus for palliation of esophageal carcinoma. J Thorac
Cardiovasc Surg. 1975 Nov;70(5):836-51.
15. Orringer MB, Sloan H. Esophagectomy without thoracotomy.
J Thorac Cardiovasc Surg. 1978 Nov;76(5):643-54.
16. Orringer MB, Skinner DB. Unusual presentations of primary and
secondary esophageal malignancies.
Ann Thorac Surg. 1971 Apr;11(4):305-14.
Competing interests: No competing interests
In his recent editorial, Michael Soljak highlights recent research
suggesting that in the majority of clinical areas studied patients treated
by physicians or hospitals with high volumes have better outcomes than
those with low volumes.(1) This has been particularly the case in surgery,
where the procedure relies primarily on individual physicians. In areas,
where the delivery of care is shared over a group or team, the evidence of
a volume-outcome relationship is less strong.(2)
The editorial also refers to a systematic review undertaken by Halm et al
which describes the current theories given for high volume being related
to better outcomes than low volume are that practice makes perfect, and
the effects of selective referral, where hospitals whose performance is
said to be good are referred to more often than other hospitals.(3) The
review goes on to criticise these theories as lacking substantial
empirical support. That is to say, there is little evidence as to reveal
exactly why bigger volume units may be related to better outcomes. Indeed
there is recognition that other reasons may exist to explain why outcomes
may be better in higher volume hospitals. Specifically it has been
suggested that some of the differences in outcomes between high and low
volume providers could be attributed to the greater uptake of specific
interventions in high than low volume hospitals.(4) There is a natural
extension of this theory that relates to the timing of the introduction of
new therapies or interventions, and how this affects the comparisons of
high and low volume hospitals. It is often the case that clinical trials
of new interventions are conducted in specialist centres or hospitals,
which in turn tend to be hospitals with high volumes. When an intervention
is found to be effective, then those patients randomised to receive that
intervention will have benefited from it, and consequently when these
hospitals are compared with other low volume hospitals it would be
expected that their outcomes appear better. In due course, once the new-
found intervention is introduced it will become generally adopted in all
hospital types. Thus the apparent improvement in the high volume hospitals
will disappear.
The above can be illustrated using an example from research conducted in
neonatal intensive care. In the United Kingdom in 1988-90 high volume
hospitals appeared to have better patient outcomes than low volume
hospitals, but in 1998-99 this effect appeared to have disappeared.(5,2)
In 1988-90 surfactant therapy was slowly being introduced to the UK. Also,
the effects of maternal steroids were being fully realised around this
time too. These two therapies, both of which have substantial proven
positive effects were administered more frequently in the high volume
hospitals than in the low volume hospitals.(6) Consequently, the
different uptakes of these therapies in low and high volume hospitals may
have contributed to the difference in their respective outcomes for the
1988-90 patients. Moving forward 10 years to 1998-99, surfactant and
maternal steroids are now routinely administered and the uptake of these
therapies is similar in high and low volume hospitals.
Furthermore,
despite on-going randomised controlled trials, there have been no new
major interventions in neonatal intensive care during the last 10 years
that have been identified and implemented. Consequently if the major
factor impacting the volume-outcome relationship in neonatal intensive
care is the uptake of effective therapies then there is little surprise
that in 1988-90 there was a difference in outcome and by 1998-99 no such
difference was observed. An alternative explanation could have been that
patients were no longer treated at hospitals whose initial risk-adjusted
mortality was high.(7) This is unlikely, because hospitals in the earlier
study did not receive feedback of their risk-adjusted outcomes until 1993.
In developing ways of improving the performance of the NHS it is important
to be aware of the effect different uptakes of new therapies have on
volume-outcome relationships. There is a need to identify and quantify the
relative importance of all factors that impact on the volume-outcome
relationship. Such knowledge would inform policymakers who also have to
weigh up issues of access to local, usually smaller hospitals and more
distant larger hospitals in a centralised service.
Dr Gareth Parry
Senior Research Fellow
Medical Care Research Unit,
University of Sheffield
Dr Janet Tucker
Senior Research Fellow
Dugald Baird Centre for Research on Women’s Health,
University of Aberdeen
Prof. William Tarnow-Mordi
Westmead and Children’s Hospital at Westmead,
University of Sydney
1. Soljak M. Volume of procedures and outcome of treatment: The NHS
needs to harness the relation more effectively. BMJ 2002;325:787-788
2. UK Neonatal Staffing Study Collaborative Group. A prospective
evaluation of patient volume, staffing and workload in relation to risk-
adjusted outcomes in a random, stratified sample of all UK neonatal
intensive care units. Lancet 2002; 359:99-107
3. Halm EA, Lee C, Chassin MR. How is volume related to quality in health
care? A systematic review of the research literature. Washington, DC:
Institute of Medicine, 2000
4. Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between
hospital volume and survival after acute myocardial infarction in elderly
patients. N Eng J Med 1999;340:1640-8
5. International Neonatal Network. The CRIB (clinical risk index for
babies) score: a tool for assessing initial neonatal risk and comparing
performance of neonatal intensive care units. Lancet 1993; 342:193-198
6. Scottish Neonatal Consultants’ Collaborative Study Group, International
Neonatal Network. Trends and variations in use of antenatal
corticosteroids to prevent neonatal respiratory distress syndrome:
recommendations for national and international comparative audit. Br J
Obstet Gynaecol 1996; 103:534-540
7. Hannon EL, Siu AL, Kumar D, Kilburn H, Chassin MR. The decline in
coronary artery bypass graft surgery mortality in New York State: The role
of surgeon volume. JAMA 1995; 273(3): 209-213
Competing interests: No competing interests
It is not surprising that there is a degree of correlation between
volume and operative mortality for as I recall from reading his book,
Social Transformation of American Medicine, Starr observed that 300 beds
was the minimum number of hospital beds required to cover all services
effectively. The correlation between volume and operative mortality for
colon cancer in the State of Maryland, for example, almost certainly
included community hospitals many of which have fewer than 300 beds (1).
If one looks solely at those hospitals with a critical mass, those with
more than 300 beds, there may be no meaningful correlation between a
surgeon’s caseload and operative mortality. Consider oesophageal surgery.
At the General Infirmary at Leeds, the largest hospital in the UK,
the outcome for 204 patients having oesophageal surgery was 12.7% (2). The
operative mortality for oesophagectomy reported by the Medical Research
Council (MRC) Oesophageal Cancer Working Party was 10% (3). Bosset et al,
who report an operative mortality of 3.2%, consider 10% unacceptably high
. Bosset at al’s operative mortality compares favourably with that
reported by Orringer and Skinner in the US (4,5). Orringer et al have
reported the largest series of transhiatal oesophagectomies in the world,
1085 cases. Their operative mortality is 4%. Skinner, reputably one or the
top two or three oesophageal surgeons in the US, report an operative
mortality of 3.9% in his group’s experiences with 128 en bloc
oesophagectomies with removal of the mediastinal nodes. Mariette et al in
France report an operative mortality of 4.7% for oesophagogastrectomy
performed for 126 patients with adenocarcinoma of the cardia (6). Thus the
operative mortality for oesophagectomies performed in credible UK
institutions of appropriate size is some two to four times higher than
that in centres of excellence in the US and France, unacceptably high.
The principle cause of adverse outcome for all major surgical
operations studied appears to by an inadequacy of gut mucosal
mitochondrial oxidative phosphorylation, identified from the presence of a
gastric intramucosal acidosis, and its putative consequences (7). The
volume of blood transfused is positively associated with an adverse
outcome. This may be because red blood cell transfusions have an equivocal
effect on the adequacy of mitochondrial oxidative phosphorylation
oxygenation and may be more likely to induce or compound the severity of
an inadequacy of oxidative phosphorylation especially if the blood is more
than fifteen days old (8). It may do so by releasing cytokines which
uncouple oxidative phosphorylation. An impairment in oxygen uptake and
utilization, which uncoupling would cause, is certainly the most
difficult of all physiological abnormalities to treat in the critically
ill.
The degree and duration of shock, defined as a gastric intramucosal
acidosis, and the volume of blood transfused must reflect to some degree
the clinical skills of the anaesthetist and technical skills of the
operating surgeon. I suspect that an unacceptable degree and/or duration
of shock and/or an unacceptably large volume of blood transfused might be
the principle causes of the unacceptably high operative mortality for
oesophagectomies in the UK. The implication is that surgeons performing
oesphagectomies in the UK are poorly trained.
Bosset et further observe that an operative mortality as low as 1%
has been achieved in other centres (3). This compares with my more modest
experience primarily working in the same centre as Orringer. If one of my
patients died I guess that my operative mortality might have been between
1% and 3% depending on whether oesophagogastrectomies were included or
not. To the best of my knowledge, however, none of my patients died
within 30 days of either an oesophagectomy or oesophagogastrectomy. If so
my operative mortality was 0% and a Chi squared or Fisher’s exact test is
likely to have shown a statistically significant difference in operative
mortalities in my and Orringer’s hands. (9). Why might my operative
mortality have been lower than Orringer’s?
Our patients came from the same pool and were cared for by the same
nurses, anesthesiologists, and residents and we had the same subspecialty
support. If anything Orringer’s residents were better trained for most of
the thoracic fellows had completed their general surgery training in our
program. Some 5% of Orringer’s patients had carcinomas in the upper third
of the oesophagus whereas none of mine did but location of tumour has not
shown to be an independent predictor of operative mortality. His series
might have included tumours that were more advanced than mine but that too
has not been shown to be an independent predictor of operative mortality.
Carcinomas in the lower third were the predominant tumours in both our
hands, and the transhiatal oesophagetomy the preferred operation.
Intrathoracic anastomoses and colonic interpositions were uncommon
operations in both series. The average blood loss in Orringer’s series was
689mls. My loss must have been very similar blood transfusion having been
rarely being indicated. Uncontrolled haemorrhage, chylous leaks, and
tracheal injuries were uncommon complications in Orringer’s large series.
I do not recall ever having had such complications but the numbers are too
small for any meaningful statistical comparison.
There were two differences in our practices that might account for
the putative difference in operative mortalities. Whereas Orringer
routinely inserted feeding jejunostomies I never did. I believe the
practice of placing jejunostomy feeding tubes in all patients may be a
practice that Orringer and possibly even Skinner acquired at Johns
Hopkins. (Halstead is the father of the Johns Hopkins surgical program). I
was not trained to place jejunostomy feeding tubes. A review of
jejunostomy feeding tubes placed in the institution, University of
Michigan Medical Center, performed by a resident revealed that their
placement was associated with a surprisingly high morbidity and even
mortality.
The other difference is that I tended to give all my patients having
a major operation a gavage with Golytley the afternoon before their
operations to cleanse their gut (9). This is not normal practice for upper
gastrointestinal or oesophageal surgery and might not have been either
Orringer’s or Skinner’s. Recent experience with colonic lavage and
diverting loop ileostomy in the management of fulminant amoebic colitis
implicates the translocation of colonic endotoxin, its release of
cytokines and possible uncoupling of oxidative phosphorylation in the
pathogenesis of adverse outcomes from either haemodynamically compensated
or uncompensated shock (10). The practice has reduced the mortality from
fulminant amoebic colitis from some 60% to 80% to 5%. The benefical
effects appears to be primarily due to the prevention of the translocation
of endotoxin and accompanying cytokine release. I have proposed,
therefore, that my practice of cleansing the bowel with Golytely before
major surgery might have been responsible for my achieving a very low
mortality in all my serious elective cases (9).
In hospitals with more than 300 and fewer than 600 or 700 beds
operative mortality would seem, therefore, to be primarily determined by
the technical training surgeons have had and the perioperative management
they provide. If so should achieving a much lower operative mortality
rather than hiring more radiotherapists and oncologists be the primary
goal in improving long term survival from oesophageal cancer? Reducing the
operative mortality from 12.7% or 10% to 1% would confer a long term
survival benefit of equivalent magnitude. Eliminating the need for blood
transfusions, which may halve long term outcome from cancer surgery, would
confer a survival benefit of 100% (7). The combination of the two would
confer a survival benefit in excess of 100%, far in excess of any
survival benefit ever achieved in the management of oesophageal cancers
with adjuvant radiotherapy and/or chemotherapy.
1. Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS,
Bender JS, Duncan MD, Magnuson TH, Lillemoe KD, Cameron JL. Hospital
volume can serve as a surrogate for surgeon volume for achieving excellent
outcomes in colorectal resection. Ann Surg. 1999 Sep;230(3):404-11;
discussion 411-3.
2. Zafirellis KD, Fountoulakis A, Dolan K, Dexter SP, Martin IG, Sue-Ling
HM. Evaluation of POSSUM in patients with oesophageal cancer undergoing
resection. Br J Surg. 2002 Sep;89(9):1150-5.
3. Jean-François Bosset, Mariette Mercier, Jean-Pierre Triboulet, Thierry
Conroy, Jean-François Seitz Surgical resection with and without
chemotherapy in oesophageal cancer Volume 360, Number 9340 12 October 2002
4. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy for
treatment of benign and malignant esophageal disease. World J Surg. 2001
Feb;25(2):196-203. Review.
5. Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves
survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997
Dec;114(6):948-55
6. Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP.
Surgical management of and long-term survival after adenocarcinoma of the
cardia. Br J Surg. 2002 Sep;89(9):1156-63.
7. Fiddian-Green RG. Failures of surgical care and outcome from cancer
surgery bmj.com/cgi/eletters/320/7239/895#7229, 31 Mar 2000
8. Fiddian-Green RG. Mitochondrial considerations
bmj.com/cgi/eletters/325/7367/735/a#26019, 4 Oct 2002
9. Fiddian-Green RG. Gastric lavage for major operations?
bmj.com/cgi/eletters/325/7366/674/b#25849, 27 Sep 2002
10. Fiddian-Green RG. Colonic lavage for severe haemorrhagic shock?
bmj.com/cgi/eletters/325/7366/674/b#25839, 27 Sep 2002
Competing interests: No competing interests
Sir,
The excellent editorial by Michael Soljak 1 leads off with the natural
assumption, (by any good New Zealander), that everybody knows who Billroth
and Halsted were. In case anyone has forgotten; a little history. Theodor
Billroth, 1829-1894, was a German surgeon, and a friend of Brahms.2
William S Halsted, 1852-1922, was a New York born surgeon, ("The father of
American surgery"), whose two years postgraduate training,from 1878 in
Europe included a period under Billroth.2
So that's that?
David S G Sloan
Public Health Physician
1 Soljak M. Volume of prodedures and outcome of treatment. BMJ
2002;325:787-8.(11 October.)
2.Duin N, Sutcliffe J. A History of Medicine. London: Simon&
Schuster,1992.
Competing interests: No competing interests
Volume of procedures and outcome of treatment
Editor - The outcome of some surgical procedures is related to the
surgeon's experience or the hospital's volume of procedures (1). This
relationship must be studied seperately for each procedure or diagnosis in
question (2).
In a study of colon surgery in the region of Copenhagen in Denmark in
1999 we found that colon surgery was performed by a large number of
surgeons in many hospitals. One hundred and two senior surgeons operated
on 674 patients but only five surgeons performed more than 14 operations
in 1999. More than 50% of the surgical procedures were carried out by
surgeons who performed fewer than 10 colon operations in 1999. Most of the
low-volume surgeons' operations were performed during calls (3). It is not
clear whether there is a positive relationship in colon surgery between
surgeon's experience and outcome (1) but if this is true the number of
surgeons performing colon surgery in our area should be limited in order
to enable a suitable number of surgeons to achieve and maintain the
necessary level of experience indicated by the evidence.
In our study we found no association between hospital volume and
surgeon volume indicating that referral of a patient to a high-volume
hospital instead of a low-volume hospital may not improve the probability
for a positive outcome. These data underscore the need for an explicit
division of tasks between the surgeons in each department in order to
ensure that surgeons achieve and maintain the necessary level of
experience.
Presumably these findings from colon surgery are applicable to other
surgical procedures, but the opportunities for concentration of a surgical
procedure on few surgeons will probably be inversely related to the amount
of the surgery performed on acute patients.
1.Soljak. M. Volume of Procedures and Outcome of treatment.
Editorial. BMJ 2002; 325: 787-8.
http://bmj.com/cgi/content/full/325/7368/787
2.Teisberg P, Hansen FH, Hotvedt R, Ingebrigtsen T, Kvalvik AG, Lund E,
Myhre HO, Skjeldestad FE, Vatten L, Norderhaug I. Hospital Volume and
Quality of Health Outcome. Oslo: The Norwegian Center for Health
Technology Assessment, 2001.
http://www.oslo.sintef.no/smm/Publications/Engsmdrag/volume.htm.
3.Birk HO, Joenler M, Jensen LP, Knudsen JL, Moesgaard F, Frimodt-Moeller
C. Surgeons' experience in colon surgery in eleven hospitals in the
Copenhagen
region in 1999. Ugeskr Laeger 2002; 164: 4537-9.
http://www.dadlnet.dk/ufl/0239/VP-html/VP38833.htm [Danish]
Hans Okkels Birk, health economist and ph.d.-student, Roskilde County
and University of Copenhagen, Department of Health Services Research.
syhob@ra.dk. Roskilde County, Kogevej 80, P.O.Box 170, DK-4000 Roskilde.
Morten Joenler, MD and ph.d., Viborg Hospital
Leif Panduro Jensen, senior surgeon, University Hospital Gentofte
Janne Lehmann Knudsen, MD and ph.d., head of quality development,
Copenhagen Hospital Corporation
Flemming Moesgaard, senior surgeon, University Hospital Herlev
Cai Frimodt-Moeller, head, senior urologist, University Hospital Gentofte
Competing interests:
None declared
Competing interests: No competing interests